Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,705.00
Bid: 1,701.00
Ask: 1,701.50
Change: 32.00 (1.91%)
Spread: 0.50 (0.029%)
Open: 1,685.50
High: 1,718.50
Low: 1,673.00
Prev. Close: 1,673.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS: Deutsche raises GSK; HSBC cuts BP to Hold

Thu, 24th Jun 2021 09:49

(Alliance News) - The following London-listed shares received analyst recommendations Thursday and Wednesday:

----------

FTSE 100

----------

DEUTSCHE BANK RAISES GLAXOSMITHKLINE TO 'HOLD' (SELL) - PRICE TARGET 1,350 (1,300) PENCE

----------

CREDIT SUISSE RAISES GLAXOSMITHKLINE PRICE TARGET TO 1,400 (1,300) PENCE - 'UNDERPERFORM'

----------

UBS RAISES SAINSBURY PRICE TARGET TO 290 (275) PENCE - 'BUY'

----------

BOFA RAISES DIAGEO PRICE TARGET TO 4,150 (3,900) PENCE - 'BUY'

----------

BERENBERG RAISES CRODA INTERNATIONAL PRICE TARGET TO 7,800 (7,400) PENCE - 'BUY'

----------

BERENBERG INITIATES PHOENIX GROUP WITH 'HOLD' - TARGET 790 PENCE

----------

CREDIT SUISSE RAISES NATWEST PRICE TARGET TO 260 (247) PENCE - 'OUTPERFORM'

----------

UBS RAISES BERKELEY GROUP PRICE TARGET TO 5,400 (5,240) PENCE - 'BUY'

----------

JEFFERIES CUTS CRH PRICE TARGET TO 4,449 (4,549) PENCE - 'BUY'

----------

CREDIT SUISSE RAISES DS SMITH PRICE TARGET TO 470 (450) PENCE - 'NEUTRAL'

----------

HSBC CUTS BP TO 'HOLD' (BUY) - PRICE TARGET 360 (365) PENCE

----------

CREDIT SUISSE CUTS SEVERN TRENT PRICE TARGET TO 2,310 (2,340) PENCE - 'NEUTRAL'

----------

FTSE 250

----------

HSBC RAISES IMI TO 'BUY' ('HOLD') - TARGET 2,065 (1,370) PENCE

----------

JPMORGAN CUTS WOOD GROUP PRICE TARGET TO 340 (350) PENCE - 'OVERWEIGHT'

----------

BERENBERG RAISES TRAVIS PERKINS PRICE TARGET TO 2050 (1910) PENCE - 'BUY'

----------

BERNSTEIN RAISES ROYAL MAIL PRICE TARGET TO 650 (575) PENCE - 'MARKET-PERFORM'

----------

BERENBERG INITIATES BEAZLEY WITH 'HOLD' - TARGET 410 PENCE

----------

BERENBERG RAISES CINEWORLD GROUP PRICE TARGET TO 85 (70) PENCE - 'HOLD'

----------

BARCLAYS RAISES WORKSPACE GROUP PRICE TARGET TO 745 (700) PENCE - 'UNDERWEIGHT'

----------

JEFFERIES RAISES OXFORD BIOMEDICA PRICE TARGET TO 1,180 (950) PENCE - 'HOLD'

----------

OTHER MAIN MARKET AND AIM

----------

BERENBERG RAISES NEXT FIFTEEN COMMUNICATIONS TARGET TO 1,140 (940) PENCE - 'BUY'

----------

JEFFERIES RAISES KERRY GROUP PRICE TARGET TO 130 (127) EUR - 'BUY'

----------

RBC RAISES SMART METERING PRICE TARGET TO 1,060 (950) PENCE - 'OUTPERFORM'

----------

BERENBERG RAISES VICTORIA PRICE TARGET TO 1,110 (1,050) PENCE - 'BUY'

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.